nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Porphyria cutanea tarda—Tamoxifen—pancreatic cancer	0.12	0.125	CcSEcCtD
Tolazamide—Porphyria non-acute—Tamoxifen—pancreatic cancer	0.113	0.117	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Docetaxel—pancreatic cancer	0.0254	0.0264	CcSEcCtD
Tolazamide—Gliclazide—VEGFA—pancreatic cancer	0.0208	0.565	CrCbGaD
Tolazamide—Eruption—Gemcitabine—pancreatic cancer	0.0195	0.0202	CcSEcCtD
Tolazamide—Heartburn—Fluorouracil—pancreatic cancer	0.0171	0.0178	CcSEcCtD
Tolazamide—Glipizide—PPARG—pancreatic cancer	0.016	0.435	CrCbGaD
Tolazamide—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.0139	0.0144	CcSEcCtD
Tolazamide—Eruption—Docetaxel—pancreatic cancer	0.0138	0.0143	CcSEcCtD
Tolazamide—Heartburn—Docetaxel—pancreatic cancer	0.0123	0.0128	CcSEcCtD
Tolazamide—Hypoglycaemia—Sunitinib—pancreatic cancer	0.0111	0.0115	CcSEcCtD
Tolazamide—Hyponatraemia—Sunitinib—pancreatic cancer	0.0109	0.0113	CcSEcCtD
Tolazamide—Pancytopenia—Tamoxifen—pancreatic cancer	0.0104	0.0108	CcSEcCtD
Tolazamide—Abdominal distension—Sunitinib—pancreatic cancer	0.00942	0.00978	CcSEcCtD
Tolazamide—Eruption—Epirubicin—pancreatic cancer	0.00931	0.00967	CcSEcCtD
Tolazamide—Hyponatraemia—Irinotecan—pancreatic cancer	0.00896	0.0093	CcSEcCtD
Tolazamide—Pancytopenia—Sunitinib—pancreatic cancer	0.00889	0.00923	CcSEcCtD
Tolazamide—Eruption—Doxorubicin—pancreatic cancer	0.00862	0.00895	CcSEcCtD
Tolazamide—Abdominal distension—Irinotecan—pancreatic cancer	0.00776	0.00806	CcSEcCtD
Tolazamide—Erythema—Tamoxifen—pancreatic cancer	0.00761	0.0079	CcSEcCtD
Tolazamide—Erythema—Erlotinib—pancreatic cancer	0.00753	0.00782	CcSEcCtD
Tolazamide—Pancytopenia—Gemcitabine—pancreatic cancer	0.00713	0.0074	CcSEcCtD
Tolazamide—Pancytopenia—Fluorouracil—pancreatic cancer	0.00701	0.00728	CcSEcCtD
Tolazamide—Leukopenia—Tamoxifen—pancreatic cancer	0.00682	0.00707	CcSEcCtD
Tolazamide—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00674	0.007	CcSEcCtD
Tolazamide—Erythema—Sunitinib—pancreatic cancer	0.00652	0.00677	CcSEcCtD
Tolazamide—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00652	0.00677	CcSEcCtD
Tolazamide—Discomfort—Tamoxifen—pancreatic cancer	0.0064	0.00665	CcSEcCtD
Tolazamide—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00625	0.00649	CcSEcCtD
Tolazamide—Hyponatraemia—Docetaxel—pancreatic cancer	0.00619	0.00643	CcSEcCtD
Tolazamide—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00614	0.00638	CcSEcCtD
Tolazamide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00608	0.00632	CcSEcCtD
Tolazamide—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00603	0.00626	CcSEcCtD
Tolazamide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00602	0.00625	CcSEcCtD
Tolazamide—Leukopenia—Sunitinib—pancreatic cancer	0.00584	0.00606	CcSEcCtD
Tolazamide—Dyspepsia—Tamoxifen—pancreatic cancer	0.00547	0.00568	CcSEcCtD
Tolazamide—Dyspepsia—Erlotinib—pancreatic cancer	0.00541	0.00562	CcSEcCtD
Tolazamide—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00538	0.00558	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00536	0.00557	CcSEcCtD
Tolazamide—Fatigue—Tamoxifen—pancreatic cancer	0.00536	0.00556	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00531	0.00551	CcSEcCtD
Tolazamide—Fatigue—Erlotinib—pancreatic cancer	0.0053	0.0055	CcSEcCtD
Tolazamide—Erythema—Gemcitabine—pancreatic cancer	0.00523	0.00543	CcSEcCtD
Tolazamide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00521	0.00541	CcSEcCtD
Tolazamide—Erythema—Fluorouracil—pancreatic cancer	0.00514	0.00534	CcSEcCtD
Tolazamide—Pancytopenia—Docetaxel—pancreatic cancer	0.00506	0.00525	CcSEcCtD
Tolazamide—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00498	0.00517	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00498	0.00517	CcSEcCtD
Tolazamide—Urticaria—Tamoxifen—pancreatic cancer	0.00494	0.00512	CcSEcCtD
Tolazamide—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00485	0.00504	CcSEcCtD
Tolazamide—Malaise—Irinotecan—pancreatic cancer	0.00484	0.00503	CcSEcCtD
Tolazamide—Vertigo—Irinotecan—pancreatic cancer	0.00483	0.00501	CcSEcCtD
Tolazamide—Leukopenia—Irinotecan—pancreatic cancer	0.00481	0.00499	CcSEcCtD
Tolazamide—Malaise—Gemcitabine—pancreatic cancer	0.00472	0.0049	CcSEcCtD
Tolazamide—Dyspepsia—Sunitinib—pancreatic cancer	0.00468	0.00486	CcSEcCtD
Tolazamide—Leukopenia—Gemcitabine—pancreatic cancer	0.00468	0.00486	CcSEcCtD
Tolazamide—Leukopenia—Fluorouracil—pancreatic cancer	0.00461	0.00478	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00459	0.00477	CcSEcCtD
Tolazamide—Fatigue—Sunitinib—pancreatic cancer	0.00459	0.00476	CcSEcCtD
Tolazamide—Discomfort—Irinotecan—pancreatic cancer	0.00452	0.00469	CcSEcCtD
Tolazamide—Asthenia—Tamoxifen—pancreatic cancer	0.00446	0.00463	CcSEcCtD
Tolazamide—Agranulocytosis—Docetaxel—pancreatic cancer	0.00443	0.0046	CcSEcCtD
Tolazamide—Asthenia—Erlotinib—pancreatic cancer	0.00441	0.00458	CcSEcCtD
Tolazamide—Discomfort—Gemcitabine—pancreatic cancer	0.0044	0.00457	CcSEcCtD
Tolazamide—Pruritus—Tamoxifen—pancreatic cancer	0.0044	0.00456	CcSEcCtD
Tolazamide—Pruritus—Erlotinib—pancreatic cancer	0.00435	0.00452	CcSEcCtD
Tolazamide—Discomfort—Fluorouracil—pancreatic cancer	0.00433	0.00449	CcSEcCtD
Tolazamide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00429	0.00446	CcSEcCtD
Tolazamide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00426	0.00442	CcSEcCtD
Tolazamide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00418	0.00434	CcSEcCtD
Tolazamide—Hyponatraemia—Epirubicin—pancreatic cancer	0.00418	0.00433	CcSEcCtD
Tolazamide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00411	0.00427	CcSEcCtD
Tolazamide—Dizziness—Tamoxifen—pancreatic cancer	0.00411	0.00427	CcSEcCtD
Tolazamide—Dizziness—Erlotinib—pancreatic cancer	0.00407	0.00422	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00394	0.00409	CcSEcCtD
Tolazamide—Rash—Tamoxifen—pancreatic cancer	0.00392	0.00407	CcSEcCtD
Tolazamide—Headache—Tamoxifen—pancreatic cancer	0.00389	0.00404	CcSEcCtD
Tolazamide—Rash—Erlotinib—pancreatic cancer	0.00388	0.00402	CcSEcCtD
Tolazamide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00386	0.00401	CcSEcCtD
Tolazamide—Dyspepsia—Irinotecan—pancreatic cancer	0.00386	0.00401	CcSEcCtD
Tolazamide—Headache—Erlotinib—pancreatic cancer	0.00385	0.004	CcSEcCtD
Tolazamide—Asthenia—Sunitinib—pancreatic cancer	0.00382	0.00396	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00378	0.00393	CcSEcCtD
Tolazamide—Fatigue—Irinotecan—pancreatic cancer	0.00378	0.00392	CcSEcCtD
Tolazamide—Pruritus—Sunitinib—pancreatic cancer	0.00377	0.00391	CcSEcCtD
Tolazamide—Erythema—Docetaxel—pancreatic cancer	0.00371	0.00385	CcSEcCtD
Tolazamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.0037	0.00384	CcSEcCtD
Tolazamide—Nausea—Tamoxifen—pancreatic cancer	0.00369	0.00383	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00369	0.00383	CcSEcCtD
Tolazamide—Fatigue—Gemcitabine—pancreatic cancer	0.00368	0.00382	CcSEcCtD
Tolazamide—Nausea—Erlotinib—pancreatic cancer	0.00365	0.00379	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00362	0.00376	CcSEcCtD
Tolazamide—Abdominal distension—Epirubicin—pancreatic cancer	0.00362	0.00376	CcSEcCtD
Tolazamide—Feeling abnormal—Irinotecan—pancreatic cancer	0.00361	0.00375	CcSEcCtD
Tolazamide—Dizziness—Sunitinib—pancreatic cancer	0.00352	0.00365	CcSEcCtD
Tolazamide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00352	0.00365	CcSEcCtD
Tolazamide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00346	0.00359	CcSEcCtD
Tolazamide—Pancytopenia—Epirubicin—pancreatic cancer	0.00341	0.00354	CcSEcCtD
Tolazamide—Rash—Sunitinib—pancreatic cancer	0.00336	0.00348	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—pancreatic cancer	0.00335	0.00348	CcSEcCtD
Tolazamide—Urticaria—Fluorouracil—pancreatic cancer	0.00334	0.00346	CcSEcCtD
Tolazamide—Headache—Sunitinib—pancreatic cancer	0.00333	0.00346	CcSEcCtD
Tolazamide—Leukopenia—Docetaxel—pancreatic cancer	0.00332	0.00345	CcSEcCtD
Tolazamide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00328	0.00341	CcSEcCtD
Tolazamide—Nausea—Sunitinib—pancreatic cancer	0.00316	0.00328	CcSEcCtD
Tolazamide—Pancytopenia—Doxorubicin—pancreatic cancer	0.00316	0.00328	CcSEcCtD
Tolazamide—Asthenia—Irinotecan—pancreatic cancer	0.00315	0.00327	CcSEcCtD
Tolazamide—Asthenia—Gemcitabine—pancreatic cancer	0.00306	0.00318	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00304	0.00315	CcSEcCtD
Tolazamide—Pruritus—Gemcitabine—pancreatic cancer	0.00302	0.00314	CcSEcCtD
Tolazamide—Agranulocytosis—Epirubicin—pancreatic cancer	0.00299	0.0031	CcSEcCtD
Tolazamide—Pruritus—Fluorouracil—pancreatic cancer	0.00297	0.00308	CcSEcCtD
Tolazamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00297	0.00308	CcSEcCtD
Tolazamide—Dizziness—Irinotecan—pancreatic cancer	0.0029	0.00301	CcSEcCtD
Tolazamide—Dizziness—Fluorouracil—pancreatic cancer	0.00278	0.00288	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00277	0.00287	CcSEcCtD
Tolazamide—Rash—Irinotecan—pancreatic cancer	0.00276	0.00287	CcSEcCtD
Tolazamide—Headache—Irinotecan—pancreatic cancer	0.00275	0.00285	CcSEcCtD
Tolazamide—Rash—Gemcitabine—pancreatic cancer	0.00269	0.0028	CcSEcCtD
Tolazamide—Headache—Gemcitabine—pancreatic cancer	0.00268	0.00278	CcSEcCtD
Tolazamide—Dyspepsia—Docetaxel—pancreatic cancer	0.00267	0.00277	CcSEcCtD
Tolazamide—Rash—Fluorouracil—pancreatic cancer	0.00265	0.00275	CcSEcCtD
Tolazamide—Headache—Fluorouracil—pancreatic cancer	0.00263	0.00273	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00262	0.00272	CcSEcCtD
Tolazamide—Fatigue—Docetaxel—pancreatic cancer	0.00261	0.00271	CcSEcCtD
Tolazamide—Nausea—Irinotecan—pancreatic cancer	0.0026	0.0027	CcSEcCtD
Tolazamide—Nausea—Gemcitabine—pancreatic cancer	0.00254	0.00263	CcSEcCtD
Tolazamide—Erythema—Epirubicin—pancreatic cancer	0.0025	0.0026	CcSEcCtD
Tolazamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.0025	0.00259	CcSEcCtD
Tolazamide—Nausea—Fluorouracil—pancreatic cancer	0.00249	0.00259	CcSEcCtD
Tolazamide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00232	0.00241	CcSEcCtD
Tolazamide—Erythema—Doxorubicin—pancreatic cancer	0.00232	0.00241	CcSEcCtD
Tolazamide—Malaise—Epirubicin—pancreatic cancer	0.00226	0.00234	CcSEcCtD
Tolazamide—Vertigo—Epirubicin—pancreatic cancer	0.00225	0.00234	CcSEcCtD
Tolazamide—Leukopenia—Epirubicin—pancreatic cancer	0.00224	0.00233	CcSEcCtD
Tolazamide—Asthenia—Docetaxel—pancreatic cancer	0.00217	0.00226	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00215	0.00223	CcSEcCtD
Tolazamide—Pruritus—Docetaxel—pancreatic cancer	0.00214	0.00223	CcSEcCtD
Tolazamide—Discomfort—Epirubicin—pancreatic cancer	0.00211	0.00219	CcSEcCtD
Tolazamide—Malaise—Doxorubicin—pancreatic cancer	0.00209	0.00217	CcSEcCtD
Tolazamide—Vertigo—Doxorubicin—pancreatic cancer	0.00208	0.00216	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—pancreatic cancer	0.00207	0.00215	CcSEcCtD
Tolazamide—Dizziness—Docetaxel—pancreatic cancer	0.002	0.00208	CcSEcCtD
Tolazamide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.002	0.00208	CcSEcCtD
Tolazamide—Discomfort—Doxorubicin—pancreatic cancer	0.00195	0.00202	CcSEcCtD
Tolazamide—Rash—Docetaxel—pancreatic cancer	0.00191	0.00198	CcSEcCtD
Tolazamide—Headache—Docetaxel—pancreatic cancer	0.0019	0.00197	CcSEcCtD
Tolazamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00185	0.00192	CcSEcCtD
Tolazamide—Nausea—Docetaxel—pancreatic cancer	0.0018	0.00187	CcSEcCtD
Tolazamide—Dyspepsia—Epirubicin—pancreatic cancer	0.0018	0.00187	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00176	0.00183	CcSEcCtD
Tolazamide—Fatigue—Epirubicin—pancreatic cancer	0.00176	0.00183	CcSEcCtD
Tolazamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.00168	0.00175	CcSEcCtD
Tolazamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.00166	0.00173	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00163	0.0017	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—pancreatic cancer	0.00163	0.00169	CcSEcCtD
Tolazamide—Urticaria—Epirubicin—pancreatic cancer	0.00162	0.00169	CcSEcCtD
Tolazamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00156	0.00162	CcSEcCtD
Tolazamide—Urticaria—Doxorubicin—pancreatic cancer	0.0015	0.00156	CcSEcCtD
Tolazamide—Asthenia—Epirubicin—pancreatic cancer	0.00147	0.00152	CcSEcCtD
Tolazamide—Pruritus—Epirubicin—pancreatic cancer	0.00145	0.0015	CcSEcCtD
Tolazamide—Asthenia—Doxorubicin—pancreatic cancer	0.00136	0.00141	CcSEcCtD
Tolazamide—Dizziness—Epirubicin—pancreatic cancer	0.00135	0.0014	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—pancreatic cancer	0.00134	0.00139	CcSEcCtD
Tolazamide—Rash—Epirubicin—pancreatic cancer	0.00129	0.00134	CcSEcCtD
Tolazamide—Headache—Epirubicin—pancreatic cancer	0.00128	0.00133	CcSEcCtD
Tolazamide—Dizziness—Doxorubicin—pancreatic cancer	0.00125	0.0013	CcSEcCtD
Tolazamide—Nausea—Epirubicin—pancreatic cancer	0.00121	0.00126	CcSEcCtD
Tolazamide—Rash—Doxorubicin—pancreatic cancer	0.00119	0.00124	CcSEcCtD
Tolazamide—Headache—Doxorubicin—pancreatic cancer	0.00118	0.00123	CcSEcCtD
Tolazamide—Nausea—Doxorubicin—pancreatic cancer	0.00112	0.00117	CcSEcCtD
